Catharina Busch, EURETINA 2018 – Developments in the Treatment of Retinal Diseases скачать в хорошем качестве

Catharina Busch, EURETINA 2018 – Developments in the Treatment of Retinal Diseases

We met with Dr Catharina Busch at EURETINA 2018 to discuss the recent developments in retinal diseases, including diabetic macular oedema and how to optimise treatment. Dr Busch also told us about the International Retina Network Group and the aims of its research. Questions: 1. What are the current unmet needs and/or the challenges you face when treating patients with retinal disease? (0:08) 2. What have been the most significant recent developments in the treatment of retinal disease? (0:39) 3.What are the key take-home messages from your presentation during the Allergan-supported satellite symposium: “Retinal Disease Management: Transferring Bench to Bedside”? (1:06) 4. What were the key highlights from this year’s meeting, and what developments are you most excited about in the area of retinal disease over the next few years? What will this mean for clinical practice? (1:28) 5. Can you give us an overview of the objectives and role of the International Retina Network Group? (1:59) Speaker disclosures: Catharina Busch has received lecture fees from Allergan and Novartis, and travel support from Allergan and Bayer. Filmed at the European Society of Retina Specialists (EURETINA) 2018 Congress, Vienna, Austria, 20–23 September 2018.